$5.38B
$587,000
0.0% of portfolio
5,819
Q4 2024
Added 65.59%
$4.04B
$354,000
0.0% of portfolio
1,576
Q2 2025
Reduced 8.58%
$18.9B
$1.42 Million
0.0% of portfolio
83,847
Q2 2025
Reduced 48.99%
$1.24B
$1.29 Million
0.0% of portfolio
54,005
Q2 2025
Reduced 34.69%
$20.3B
$316,000
0.0% of portfolio
1,681
Q2 2025
Reduced 96.86%
$8.8B
$509,000
0.0% of portfolio
39,494
Q2 2025
Added 0.79%
$786M
$2.11 Million
0.0% of portfolio
150,000
Q2 2024
Reduced 25.0%
$842M
$980,000
0.0% of portfolio
56,631
Q2 2025
New
$51.8B
$2.24 Million
0.0% of portfolio
7,644
Q2 2025
Reduced 26.12%
$13.7B
$1.15 Million
0.0% of portfolio
5,820
Q2 2025
Reduced 87.77%
$751M
$842,000
0.0% of portfolio
64,431
Q2 2025
Reduced 1.0%
$11.8B
$2.39 Million
0.0% of portfolio
13,269
Q2 2025
Reduced 70.1%
$27.3B
$1.4 Million
0.0% of portfolio
8,412
Q2 2025
Added 11.24%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 16.05%
$46.1B
$1.99 Million
0.0% of portfolio
14,348
Q4 2024
Added 1.06%
$3.4B
$926,000
0.0% of portfolio
29,798
Q2 2024
New
$10.3B
$600,000
0.0% of portfolio
12,049
Q2 2025
Reduced 49.49%
$16.6B
$1.39 Million
0.0% of portfolio
21,330
Q2 2025
Reduced 74.78%
$12.6B
$702,000
0.0% of portfolio
45,737
Q2 2025
Reduced 89.59%
$14.6B
$376,000
0.0% of portfolio
2,625
Q2 2025
Reduced 77.08%
$14.3B
$462,000
0.0% of portfolio
3,179
Q2 2025
Reduced 18.45%
$593M
$481,000
0.0% of portfolio
16,967
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Added 1,708.62%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 77.95%
$5.21B
$184,000
0.0% of portfolio
63,226
Q2 2025
Reduced 86.11%
$5.73B
$1.63 Million
0.0% of portfolio
48,491
Q2 2025
Reduced 61.61%
$13.9B
$1.36 Million
0.0% of portfolio
10,980
Q2 2025
Reduced 30.78%
$14.5B
$2.18 Million
0.0% of portfolio
25,310
Q2 2025
Added 3.66%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
New
$1.57B
$2.87 Million
0.0% of portfolio
1,312,678
Q2 2025
Added 7.21%
$2.48B
$2.87 Million
0.0% of portfolio
106,741
Q2 2025
Added 3.18%
$1.98B
$1.48 Million
0.0% of portfolio
46,787
Q2 2025
New
$1.65B
$1.22 Million
0.0% of portfolio
8,000
Q2 2025
New
$81.8B
$2.89 Million
0.0% of portfolio
11,687
Q2 2025
Reduced 42.01%
$1.35B
$577,000
0.0% of portfolio
28,742
Q3 2024
Reduced 36.16%
-
$0
0.0% of portfolio
-
Q2 2025
Added 101.23%
$9.07B
$502,000
0.0% of portfolio
10,261
Q2 2025
Reduced 4.99%
$4.78B
$1.37 Million
0.0% of portfolio
58,407
Q2 2025
New
$2.05B
$766,000
0.0% of portfolio
86,012
Q2 2025
Added 169.71%
-
$0
0.0% of portfolio
-
Q1 2025
Added 172.7%
-
$0
0.0% of portfolio
-
Q2 2025
Added 17.63%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 6.97%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 4.34%
$11.2B
$1.58 Million
0.0% of portfolio
16,609
Q2 2025
Added 50.19%
$34.2B
$610,000
0.0% of portfolio
3,145
Q2 2025
Reduced 72.77%
-
$0
0.0% of portfolio
-
Q2 2025
Added 94.77%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 55.66%
Kiniksa Pharmaceuticals Intl
-
$0
0.0% of portfolio
-
Q2 2025
New
$4.84B
$2.02 Million
0.0% of portfolio
52,914
Q2 2025
New